These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 17443580)

  • 1. Fish oil for kidney transplant recipients.
    Lim AK; Manley KJ; Roberts MA; Fraenkel MB
    Cochrane Database Syst Rev; 2007 Apr; (2):CD005282. PubMed ID: 17443580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fish oil for kidney transplant recipients.
    Lim AK; Manley KJ; Roberts MA; Fraenkel MB
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD005282. PubMed ID: 27535773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fish oil treatment for kidney transplant recipients: a meta-analysis of randomized controlled trials.
    Lim AK; Manley KJ; Roberts MA; Fraenkel MB
    Transplantation; 2007 Apr; 83(7):831-8. PubMed ID: 17460552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Belatacept for kidney transplant recipients.
    Masson P; Henderson L; Chapman JR; Craig JC; Webster AC
    Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD010699. PubMed ID: 25416857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HMG CoA reductase inhibitors (statins) for kidney transplant recipients.
    Navaneethan SD; Perkovic V; Johnson DW; Nigwekar SU; Craig JC; Strippoli GF
    Cochrane Database Syst Rev; 2009 Apr; (2):CD005019. PubMed ID: 19370615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycophenolic acid versus azathioprine as primary immunosuppression for kidney transplant recipients.
    Wagner M; Earley AK; Webster AC; Schmid CH; Balk EM; Uhlig K
    Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD007746. PubMed ID: 26633102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cordyceps sinensis (a traditional Chinese medicine) for kidney transplant recipients.
    Hong T; Zhang M; Fan J
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD009698. PubMed ID: 26457607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppressive T-cell antibody induction for heart transplant recipients.
    Penninga L; Møller CH; Gustafsson F; Gluud C; Steinbrüchel DA
    Cochrane Database Syst Rev; 2013 Dec; (12):CD008842. PubMed ID: 24297433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steroid avoidance or withdrawal for kidney transplant recipients.
    Pascual J; Zamora J; Galeano C; Royuela A; Quereda C
    Cochrane Database Syst Rev; 2009 Jan; (1):CD005632. PubMed ID: 19160257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steroid avoidance or withdrawal for pancreas and pancreas with kidney transplant recipients.
    Montero N; Webster AC; Royuela A; Zamora J; Crespo Barrio M; Pascual J
    Cochrane Database Syst Rev; 2014 Sep; 2014(9):CD007669. PubMed ID: 25220222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steroid avoidance or withdrawal for kidney transplant recipients.
    Haller MC; Royuela A; Nagler EV; Pascual J; Webster AC
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD005632. PubMed ID: 27546100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocorticosteroid-free versus glucocorticosteroid-containing immunosuppression for liver transplanted patients.
    Fairfield C; Penninga L; Powell J; Harrison EM; Wigmore SJ
    Cochrane Database Syst Rev; 2015 Dec; (12):CD007606. PubMed ID: 26666504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcineurin inhibitor minimisation versus continuation of calcineurin inhibitor treatment for liver transplant recipients.
    Penninga L; Wettergren A; Chan AW; Steinbrüchel DA; Gluud C
    Cochrane Database Syst Rev; 2012 Mar; 2012(3):CD008852. PubMed ID: 22419339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin 2 receptor antagonists for kidney transplant recipients.
    Webster AC; Ruster LP; McGee R; Matheson SL; Higgins GY; Willis NS; Chapman JR; Craig JC
    Cochrane Database Syst Rev; 2010 Jan; 2010(1):CD003897. PubMed ID: 20091551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody induction versus corticosteroid induction for liver transplant recipients.
    Penninga L; Wettergren A; Wilson CH; Chan AW; Steinbrüchel DA; Gluud C
    Cochrane Database Syst Rev; 2014 May; 2014(5):CD010252. PubMed ID: 24880007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipients.
    Webster A; Woodroffe RC; Taylor RS; Chapman JR; Craig JC
    Cochrane Database Syst Rev; 2005 Oct; (4):CD003961. PubMed ID: 16235347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients.
    Penninga L; Penninga EI; Møller CH; Iversen M; Steinbrüchel DA; Gluud C
    Cochrane Database Syst Rev; 2013 May; (5):CD008817. PubMed ID: 23728681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet-rich therapies for musculoskeletal soft tissue injuries.
    Moraes VY; Lenza M; Tamaoki MJ; Faloppa F; Belloti JC
    Cochrane Database Syst Rev; 2013 Dec; (12):CD010071. PubMed ID: 24363098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary fish oil does not influence acute rejection rate and graft survival after renal transplantation: a randomized placebo-controlled study.
    Hernández D; Guerra R; Milena A; Torres A; García S; García C; Abreu P; González A; Gómez MA; Rufino M; González-Posada J; Lorenzo V; Salido E
    Nephrol Dial Transplant; 2002 May; 17(5):897-904. PubMed ID: 11981081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycophenolate mofetil versus methotrexate for prevention of graft-versus-host disease in people receiving allogeneic hematopoietic stem cell transplantation.
    Kharfan-Dabaja M; Mhaskar R; Reljic T; Pidala J; Perkins JB; Djulbegovic B; Kumar A
    Cochrane Database Syst Rev; 2014 Jul; 2014(7):CD010280. PubMed ID: 25061777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.